IFF Earnings Call Highlights Growth, Cash Flow and Risks

International Flavors & Fragrances (IFF) reported Q3 revenue of $2B, up 5% YoY. EBITDA rose 6% to $403M, with margins expanding 20 bps. Management raised full-year targets but cited risks like soft Health markets and inflation. Free cash flow surged to $371M, and $500M in shares were repurchased. IFF expects Q4 growth to slow to 3% and margin pressure in Health & Biosciences.

Original reporting
Published Nov 12, 2026, 12:19 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$IFF
Neutral
medium confidence
Mentioned
$IFF
Relevance
4/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$IFFNeutralLow
01

Why it matters

The recap reinforces existing expectations; no new catalyst to move the stock significantly.

02

Market read

Company‑specific earnings recap with modest guidance concerns; limited broader market effect.

03

What to watch

Potential upside from the pending $4.3 B Food Ingredients divestiture not yet reflected in price.

Relevance 4/10Novelty 2/10Timing: post‑earnings recap

Background

International Flavors & Fragrances (IFF) reported Q3 results earlier this month; the article repeats those figures and adds commentary on upcoming transactions.

Company-level read

Ticker impact

$IFFNeutralMedium confidence
Context

Recap of Q3 earnings call with updated revenue, EBITDA, cash flow and guidance; no new primary disclosure.

Expected impact

likely slight downside as investors digest margin pressure guidance

Evidence & confidence

All numbers were already public after the 2026-11-03 release; the article adds no fresh catalyst.

Market effects

Flavor and fragrance sector sees steady growth but margin pressure signals caution.

Asia sales strong; Europe and North America mixed, no broad regional shift.

Limited; company‑specific recap without macro impact.

Counterpoint

Investors could view the strong cash flow and buyback as a floor, supporting a neutral stance.

Key entities

  • International Flavors & Fragrances

    US‑listed flavor and fragrance producer (ticker IFF).

  • CBC Capital Partners

    Buyer of IFF's Food Ingredients business.

Related articles

$IFFMedAI 8/10

International Flavors & Fragrances Q3 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q3 sales of $566M in Health & Biosciences, up 1%. Full-year sales are expected to be $7.5B-$7.6B, with adjusted EBITDA of $1.55B-$1.6B. IFF faces cost pressures, particularly in Health & Biosciences, due to higher input costs. The company plans to divest its Food Ingredients business for $4.3B by mid-2027 and has completed other divestitures. Free cash flow for the first nine months of 2026 was $371M, up $245M year-over-year.

$IFFMed

International Flavors & Fragrances Inc (IFF) (Q3 2026) Earnings Call

International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.